Jia Chengyou, Medina Vivian, Liu Chenchang, He Lina, Qian Daohai, Taojian Tu, Okamoto Curtis T, Stiles Bangyan L
Department of Nuclear Medicine, Central Laboratory for Medical Research, Shanghai 10th People's Hospital, Tongji University School of Medicine, Shanghai 200072, China.
Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Southern California, Los Angeles, CA 90033.
Hepatol Commun. 2017 Apr;1(2):153-167. doi: 10.1002/hep4.1027. Epub 2017 Apr 1.
Liver kinase B 1 (LKB1 or STK11) and PTEN (phosphatase and tensin homologue deleted on chromosome 10) are two tumor suppressors that regulate the mTOR signaling pathway. Deletion studies show that loss of either ( ) or ( ) leads to liver injury and development of hepatocarcinoma. In this study, we investigated the crosstalk of LKB1 and PTEN loss during tumorigenesis and liver development. We show here that haplo-insufficiency of in the liver leads to advanced tumor development in the null mice ( ). Our analysis shows that LKB1 and PTEN interacted with each other in their regulation of fatty acid synthase as well as p21 expression. The combined loss of LKB1 and PTEN ( ) also led to the inability to form zonal structures in the liver. The lack of metabolic zonal structures is consistent with the inability of the livers to store glycogen as well as elevated plasma bilirubin and alanine aminotransferase (ALT), indicative of liver dysfunction. These structural and functional defects are associated with cytoplasm distribution of a canalicular membrane protein MRP2 (multidrug resistant protein 2) which is responsible for clearing bilirubin. This observed regulation of MRP2 by LKB1 likely contributed to the lack of cellular polarity and the early lethality phenotype associated with homozygous loss of alone or in combination with . Finally, deletion does not rescue the precocious ductal plate formation reported for deleted livers.
Our study dissected the functional and molecular crosstalk of PTEN and LKB1 and elucidate key molecular targets for such interaction.
肝脏激酶B1(LKB1或STK11)和PTEN(第10号染色体缺失的磷酸酶和张力蛋白同源物)是两种调节mTOR信号通路的肿瘤抑制因子。缺失研究表明,LKB1或PTEN的缺失都会导致肝损伤和肝癌的发生。在本研究中,我们调查了LKB1和PTEN缺失在肿瘤发生和肝脏发育过程中的相互作用。我们在此表明,肝脏中LKB1单倍体不足会导致PTEN基因敲除小鼠(PTEN-/-)的肿瘤进展加快。我们的分析表明,LKB1和PTEN在调节脂肪酸合酶以及p21表达方面相互作用。LKB1和PTEN的联合缺失(LKB1-/-/PTEN-/-)还导致肝脏无法形成区域结构。缺乏代谢区域结构与肝脏无法储存糖原以及血浆胆红素和丙氨酸转氨酶(ALT)升高一致,这表明肝功能障碍。这些结构和功能缺陷与负责清除胆红素的胆小管膜蛋白MRP2(多药耐药蛋白2)的细胞质分布有关。观察到的LKB1对MRP2的这种调节可能导致了缺乏细胞极性以及与单独或联合LKB1纯合缺失相关的早期致死表型。最后,LKB1缺失并不能挽救PTEN缺失肝脏中报道的早熟导管板形成。
我们的研究剖析了PTEN和LKB1的功能和分子相互作用,并阐明了这种相互作用的关键分子靶点。